Oral Cardiovascular Management for Dogs
Enalapril Maleate Tablets are veterinary oral tablets intended for long-term cardiovascular management in dogs. Each standard tablet contains 2.5 mg of enalapril maleate, and customized specifications are available.
The tablet format supports controlled individual administration. Clear strength labeling is important because treatment is linked to the dog's condition and ongoing veterinary plan. Pet-product packaging can also be customized for different branding and distribution requirements.
Heart Failure and Hypertension Applications
The product is suitable for dogs requiring management of congestive heart failure or hypertension. Administration should follow veterinary instructions and should remain consistent with the prescribed treatment plan.
The medicine should not be stopped without veterinary guidance. Regular follow-up examinations are required according to the supplied use information. These reviews help the veterinarian assess the dog's condition and determine whether the existing plan should continue.
Owners should not change the dose or treatment schedule independently. Continued breathing difficulty, weakness, reduced activity, or other changes in condition require professional veterinary assessment.
GMP Tablet Manufacturing
Production takes place on a GMP pet-tablet line. Tablet disintegration is fully inspected as part of the quality-control process.
This inspection provides buyers with a specific manufacturing parameter related to the tablet's breakdown after administration. The product strength, ingredient, target animal, and intended use should remain clearly identified on the final packaging.
OEM Packaging Service
Pet OEM service is available, with a minimum order quantity of 1,000 pieces. Customized packaging can be prepared according to private-label and market-presentation requirements.
The external presentation may be adjusted while keeping the supplied product information accurate and visible. This supports buyers who need a branded canine cardiovascular tablet for professional pet-care channels.
Export Case Showcase
Customer Type
International pet medicine distributors, veterinary hospitals, and companion animal healthcare suppliers.
01
Customer Demand
Customers required reliable cardiovascular management products for long-term veterinary care of dogs.
02
Product Supply Solution
We provide Enalapril Maleate Tablets featuring:
Dosage form: Pet cardiovascular tablets
Specification: 2.5 mg/tablet
Active ingredient: Enalapril Maleate
Target animal: Dogs
Packaging: 8 tablets/blister × 2 blisters/box
03
Application Scenario
The product is used in veterinary cardiovascular management programs, including canine heart failure and blood pressure management, under professional veterinary monitoring.
04
Export Cooperation Features
The 2.5 mg tablet specification allows flexible dose adjustment according to veterinary evaluation, making it suitable for long-term companion animal healthcare distribution.
05
Product Specifications
|
Item |
Specification |
|
Generic Name |
Enalapril Maleate Tablets |
|
Dosage Form / Strength |
Veterinary cardiovascular tablet; 2.5 mg/tablet; customizable |
|
Active Ingredient |
Enalapril maleate |
|
Target Animals |
Dogs requiring heart-failure or hypertension management |
|
Packaging |
Customizable |
Hot Tags: enalapril maleate tablets, China enalapril maleate tablets manufacturers, suppliers, factory, Cimetidine Tablets, Compound Ketoconazole Ointment, Enalapril Maleate Tablets, Meloxicam Tablets, Neomycin Sulfate Eye Drops, pet medications
